Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mihaela Barbu

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Maedica|December 9, 2017
A Comparative Study of Efficacy and Safety of Two Eradication Regimens for Helicobacter pylori InfectionCarmen Monica Preda, Doina Proca, Irina Sandra, et al.
Haematologica|February 9, 2018
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients with sickle cell disease: interim resultsFarid Boulad, Tsiporah Shore, Koen van Besien, et al.
Haematologica|September 2, 2018
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients with sickle cell disease: interim resultsFarid Boulad, Tsiporah Shore, Koen van Besien, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Maedica|December 9, 2017
A Comparative Study of Efficacy and Safety of Two Eradication Regimens for Helicobacter pylori InfectionCarmen Monica Preda, Doina Proca, Irina Sandra, et al.
Haematologica|February 9, 2018
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients with sickle cell disease: interim resultsFarid Boulad, Tsiporah Shore, Koen van Besien, et al.
Haematologica|September 2, 2018
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients with sickle cell disease: interim resultsFarid Boulad, Tsiporah Shore, Koen van Besien, et al.
Pageof 2